[ad_1] Medical cannabis activists and patients in Spain had reason to celebrate after the Spanish government’s decision in June to legalize access to medicinal cannabis for a number of health conditions through the country’s public health system. Although Spanish scientists for several years have been at the forefront of ground-breaking cannabinoid research on cancer and neurological diseases, getting a prescription for standardized and regulated medicinal cannabis products from a doctor was not on the table…
"Spanish Government Gives Green Light to Medical Cannabis"Category: CBD
[ad_1] A new study of medical cannabis patients finds considerable variability in product choice – even among those with the same condition – suggesting a lack of consistent clinical guidance. Until now, understanding what products medical cannabis patients use for various conditions has mostly come from survey responses due to a lack of publicly available data. In a new study, USC Schaeffer Center researchers have established a clearer picture by analysing point-of-sale data from nearly…
"Product preferences among medical cannabis patients"
[ad_1] On August 17, the First Circuit Court of Appeals affirmed the the holding of the US District Court for the District of Maine that the residency requirements of Maine’s Medical Use Marijuana Act violate the Dormant Commerce Clause (“DCC”). The First Circuit has added itself to the list of jurisdictions that have invalidated similar state cannabis laws on DCC grounds, including in the Sixth and Eighth circuits. Northeast Patients Group (“Northeast”) and High Street…
"Federal Appeals Court: Maine’s Cannabis Licensee Residency Requirement is Unconstitutional"
[ad_1] The psychedelic renaissance is upon us, with myriad research showing how substances like psilocybin, LSD, and more aid in mental health conditions like treatment-resistant depression and PTSD. More and more, the curiosity around psychedelics is increasing, with individuals seeing the potential of these mind-bending medicines to overcome perceived limits of the self. At the same time, technology continues to evolve at a rapid pace, posing the question: Could tech like virtual reality provide comparable…
"New VR Tech Emulates Psychedelic Experience"
[ad_1] Whether you’re a first-time user or an experienced user, understanding how CBD works and how to use it can be somewhat confusing, especially since the industry is so new. Every day, we answer dozens of questions from our readers, but one of the most frequently asked by first-time users and experienced users alike is: What’s the best CBD dosage? While there are tons of articles about the benefits of CBD, there are few about…
"“What’s the Best CBD Dosage?” The Official Guide"
[ad_1] The Case for Euphoria as an Added Benefit in the Healing Process Reddit link on the debate is here. When you feel ill, unwell, unhealthy, bad…a physician will prescribe you some medicine and would urge you to rest. In most cases, the pharmaceuticals will reduce the symptoms and potentially make you drowsy (and some other side effects too) and if all goes well…you’ll get better. Irrespective of the pharma med they…
"Recreational vs. Medical Marijuana Labeling"
[ad_1] The U.S. cannabis industry is projected to be worth $100 billion USD by 2030, and MERCHtender is dedicated to helping smaller cannabis brands get their piece of the pie. At a time in our nation’s history when we could very well see the federal legalization of marijuana happen within the next couple of years, MERCHtender gives the “moms and pops” of cannabis farmers, distributors, and brands a boost by helping them to better connect with their customers…
"A Nutshell Customer Story: MERCHtender"
[ad_1] A cannabinoid is any molecule that interacts with at least one of the body’s two cannabinoid receptors, CB1 and CB2. This large class of chemicals can be divided into three parts: those produced by cannabis, called phytocannabinoids; those produced within the body, called endogenous cannabinoids or endocannabinoids; and those produced in a lab (that don’t also exist in nature), called synthetic cannabinoids. It’s this latter class of novel molecules, encompassing valuable research chemicals and…
"The Risky Business of Synthetic Highs"
[ad_1] Dr. Miyabe Shields, PhD and Dr. Riley Kirk, PhD are using platforms like TikTok and Instagram to … [+] promote cannabis pharmacology education. They’ve also collected data from thousands of respondents about their cannabis use. Courtesy photo Love it or hate it, social media can be a powerful tool for education and data collection. While the subject of cannabis often triggers the removal of content and banned accounts, pharmaceutical scientists Dr. Riley Kirk, PhD…
"Meet The Two Radical Scientists Using TikTok To Make Cannabis Education Accessible"
[ad_1] Yesterday, Senator Majority Leader Chuck Schumer and Senators Cory Booker and Ron Wyden presented the Cannabis Administration and Opportunity Act (CAOA) in the Senate. This version of the CAOA is a big deal, as it’s been over a year since the discussion draft of the bill was shown to the public. It’s also a big deal because we finally have a meaningful cannabis bill (with the input of many, many stakeholders) originating from the…
"Federal Cannabis Legislation: The CAOA is Back!"